Akeso Inc
HKEX:9926
Akeso Inc
HKEX:9926
Price:
104.7
HKD
2.95%
Market Closed
Market Cap:
HK$96.4B
Relative Value
The Relative Value of one
Akeso Inc
stock under the Base Case scenario is
57.77
HKD.
Compared to the current market price of 104.7 HKD,
Akeso Inc
is
Overvalued by 45%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
57.77
HKD
Overvaluation 45%
Multiples Across Competitors
Competitors Multiples
Akeso Inc Competitors
Akeso Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Akeso Inc
HKEX:9926
|
94B HKD | 33.3 | -98.8 | -123.6 | -89.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
396B USD | 6.7 | 168.9 | 16.4 | 23.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202.6B USD | 5.4 | 25.6 | 14.7 | 14.7 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
188B USD | 6.4 | 23 | 15.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.6B USD | 10.2 | 32.5 | 23.9 | 24.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18 | 15.3 | 17.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
89B AUD | 4 | 20.6 | 13.8 | 17.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
42.7B EUR | 14.4 | 33.8 | 57.7 | 59.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
